Central Pharma sees losses for 3rd year
Central Pharmaceuticals Ltd suffered losses for the third consecutive year in 2021-22.
Central Pharmaceuticals Ltd suffered losses for the third consecutive year in 2021-22.
It incurred a loss of Tk 6.83 crore in the year that ended on June 30 this year. The loss stood at Tk 83.86 lakh in 2020-21.
Thus, the drugs maker reported earnings per share of Tk 0.57 in negative for 2021-22, which was Tk 0.07 in negative in 2020-21.
The net asset value per share of Central Pharmaceuticals dropped to Tk 5.96 from Tk 6.53 a year earlier.
The net operating cash flow per share was Tk 0.01 in negative in 2021-22 from a positive Tk 0.01 a year earlier. The board did not recommend dividends for 2021-22.
Shares of Central Pharma closed unchanged at Tk 12.40 on the Dhaka Stock Exchange yesterday.
Comments